SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

FTH

Faeth Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3d 7h ago SEC0000919574-26-007764
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to a 13D filing, which would signal activist intent. The passive nature of this stake suggests no near-term governance changes.

DirectionNeutral
Confidencehigh
Horizonweeks
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Montanova Capital, LLC filed an amended Schedule 13G disclosing a 8.9% passive stake in Faeth Therapeutics as of September 30, 2026. The filing is an initial 13G/A from this filer; no prior Montanova 13G is in the cross-filing context, so this is a new disclosure of a 2,310,703-share position. A passive holder crossing 5% is neutral by default.

Key Financial Metrics

Stake
8.9%
Investor
Montanova Capital, LLC
Investor Type
hedge fund

Key Facts

  • Montanova Capital, LLC reports beneficial ownership of 2,310,703 shares of Faeth Therapeutics common stock, representing 8.9% of shares outstanding.
  • Averill Master Fund, Ltd., an advisory client of Montanova, directly holds 1,969,872 shares (7.6%).
  • Aaron Cowen is the control person of Montanova Capital, LLC.
  • The filing is an initial Schedule 13G/A from Montanova; no prior Montanova 13G was found in the cross-filing context.
  • The filer certifies the securities were not acquired to change or influence control of the issuer.

Financial Impact

8.9% passive stake valued at approximately $30.7M based on $345M market cap.

ownership

Risk Factors

  • Passive 13G filer could later convert to 13D and become activist.
  • No stated intention to increase or decrease position.

Market Snapshot

Exchange
Nasdaq
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000919574-26-007764
Document: p15120128_ex-b.htm0000919574-26-007764
Document: 0000919574-26-007764-index-headers.html0000919574-26-007764
Document: 0000919574-26-007764-index.html0000919574-26-007764
Document: 0000919574-26-007764.txt0000919574-26-007764

Track record

12 reports on FTH

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +35.00% at T+60 after the Aug 11, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $10.03 Now $9.28 −7.48% settles Nov 17
  3. Nov 9, 20267d ago 8-K Bullish 6/10 Entry $12.68 to $12.92 Now $9.28 −26.81% ▲ +1.89% +2.26% vs SPY
  4. Nov 9, 20267d ago 8-K Bullish 6/10 Entry $12.68 to $12.92 Now $9.28 −26.81% ▲ +1.89% +2.26% vs SPY
  5. Nov 3, 202613d ago 8-K Neutral 5/10 Entry $19.65 to $19.99 Now $9.28 −52.77% ▲ +1.73% +0.08% vs SPY
  6. Oct 27, 202620d ago 3 Neutral 2/10 Entry $19.20 to $18.75 Now $9.28 −51.67% ▼ −2.34% −1.96% vs SPY
  7. Oct 27, 202620d ago 8-K Neutral 2/10 Entry $19.11 to $19.20 Now $9.28 −51.44% ▲ +0.47% +0.13% vs SPY
  8. Sep 15, 20268w ago 3 Neutral 2/10 Entry $34.24 to $35.13 Now $9.28 −72.90% ▲ +2.60% +1.47% vs SPY
  9. Aug 11, 202613w ago 144 Bearish 5/10 Entry $30.00 to $29.38 Now $9.28 +69.07% ▲ +2.07% +2.32% vs SPY
  10. Aug 4, 202614w ago 8-K Neutral 3/10 Entry $25.50 to $24.59 Now $9.28 −63.61% ▼ −3.57% −3.37% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Wed (10h 15m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026